Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03850106 · ClinicalTrials.gov registry record · NA
Effects of INDUS810 on Body Composition, Muscular Performance, and Training Adaptations
A NA study, sponsored by The Center for Applied Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT03850106 is a NA study that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 67 participants.
The verdict
NCT03850106, a NA study, has completed, sponsored by The Center for Applied Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
The purpose of this 12-week, interventional study is to determine the effects of oral supplementation with Indus810 (dietary supplement with active ingredient Fenugreek) on body composition, muscular performance, and training adaptations
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Indus810
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2018-07-11 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03850106
The ClinicalTrials.gov registry entry for NCT03850106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Center for Applied Health Sciences, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03850106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03850106 about?
NCT03850106 is a clinical study titled "Effects of INDUS810 on Body Composition, Muscular Performance, and Training Adaptations". The purpose of this 12-week, interventional study is to determine the effects of oral supplementation with Indus810 (dietary supplement with active ingredient Fenugreek) on body composition, muscular performance, and training adaptations
What is the current status of trial NCT03850106?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2018-07-11. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT03850106?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Indus810 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03850106?
This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.